FILTER CONTENT

Filters
Company Names

Research

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: December 19, 2022

    7investing’s 2022 Year in Review: An Updated Look at All of Our Stock Picks

  • The word update written on a chalkboard.
    By Published On: November 21, 2021

    7investing Company Update Roundup: November 2021

  • The 7investing logo next to the Intellia Therapeutics logo.
    By Published On: November 8, 2021

    Sell Intellia Therapeutics

  • The word update written on a chalkboard.
    By Published On: October 21, 2021

    7investing Company Update Roundup: October 2021

  • 7investing's logo next to the Cellectis logo.
    By Published On: October 10, 2021

    Cellectis Tumbles on Allogene’s Pipeline-Wide Clinical Hold

  • The word update written on a chalkboard.
    By Published On: July 21, 2021

    7investing Company Update Roundup: July 2021

  • The 7investing logo next to the Intellia Therapeutics logo.
    By Published On: July 3, 2021

    Intellia Therapeutics Crushes In Vivo Data Readout. What’s Next?

  • The 7investing logo next to the Intellia Therapeutics logo.
    By Published On: June 27, 2021

    The First In Vivo CRISPR Gene Editing Data are Coming

  • The word update written on a chalkboard.
    By Published On: April 22, 2021

    7investing Company Update Roundup: April 2021

  • The 7investing logo next to the Intellia Therapeutics logo.
    By Published On: April 20, 2021

    What Opportunities and Challenges Await Intellia Therapeutics?

  • The 7investing logo next to the Intellia Therapeutics logo.
    By Published On: January 8, 2021

    Intellia Deep-Dive: January 2021